(MedPage Today) — Turing Pharmaceuticals drops the price of its antiinfective drug
Response to Anti-VEGF in Macular Edema Evident at 3 Months
Response to anti-VEGF injections at 3 months is predictive of response at 1 and 3 years, so nonresponders can be switched to a drug with a different mechanism of action early on, researchers report. Medscape Medical News
Research and Markets: Sustained Release Ocular Drug Delivery Systems Market to Reach USD 6.5 Billion by 2025 – Market Analysis and Forecast 2015 – 2025 (2nd edition)
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/sz483m/sustained_release) has announced the addition of the “Sustained Release Ocular Drug Delivery Systems, 2015 – 2025 (2nd edition)” report to their offering. …
Uncategorized
Spark Therapeutics reports $16.9 million net loss in third quarter
Spark Therapeutics reported a net loss of $16.9 million, or $0.70 per basic and diluted share, in the third quarter compared with a net loss of $6.8 million, or $1.22 per basic and diluted share, in the same quarter of 2014, according to a press releas…
York research points to enhanced detection of Parkinson’s
New research by biologists at the University of York could lead to improved methods of detection for early-onset Parkinson’s disease.
Largest Prospective Study Evaluating the Effect of Vigabatrin on Vision
PHILADELPHIA–(BUSINESS WIRE)–The largest prospective study evaluating the effect of vigabatrin on vision will be available to view at the annual meeting of the American Epilepsy Society (AES) in Philadelphia.